Daniel A Tatosian

Title: The Innovations of Daniel A. Tatosian

Introduction

Daniel A. Tatosian is a notable inventor based in Berkeley Heights, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions. With a total of 2 patents to his name, Tatosian's work is recognized for its potential impact on treating serious health issues.

Latest Patents

Tatosian's latest patents focus on Factor XI activation inhibitors. The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds. These compounds are designed for treating or preventing thromboses, embolisms, hypercoagulability, or fibrotic changes. The compounds are selective Factor XI activation inhibitors, showcasing Tatosian's commitment to advancing medical science.

Career Highlights

Daniel A. Tatosian is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck allows him to collaborate with other experts in the field and contribute to innovative solutions in medicine. His work is characterized by a focus on developing effective treatments that can improve patient outcomes.

Collaborations

Tatosian has worked alongside talented colleagues, including Jacqueline D. Hicks and John S. Debenham. These collaborations have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.

Conclusion

Daniel A. Tatosian's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to improving healthcare. His work on Factor XI activation inhibitors is a testament to his innovative spirit and commitment to addressing critical medical challenges.